Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Demographic data and OA history

From: Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial

Patients  
N 22 (M: 7-F: 15)
Age 64.3 ± 8.4 years
Pain history 48.5 ± 48.2 months
Knee pain  
- Left 4.6%
- Right 31.8%
- Both 63.6%
Radiographic knee OA severity score (K&L)  
- I 13.6%
- II 50.0%
- III 31.8%
- IV 4.6%
Night pain  
  -Yes 59.1%
  -No 40.9%
Effusion  
  -Yes 31.8%
  -No 68.2%